[Analysis of the efficiency of Gerigoa-depot in a double-blind study].
D000368:Aged; D002986:Clinical Trials as Topic; D003692:Delayed-Action Preparations; D003704:Dementia / Q000188:drug therapy*; D004338:Drug Combinations; D004341:Drug Evaluation; D005260:Female; D006415:Hematoporphyrins / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D008875:Middle Aged; D009756:Nylidrin / Q000627:therapeutic use*; D010919:Placebos; D011343:Procaine / Q000627:therapeutic use*; D014815:Vitamins / Q000627:therapeutic use
D003692:Delayed-Action Preparations; D004338:Drug Combinations; D006415:Hematoporphyrins; D010919:Placebos; D014815:Vitamins; D011343:Procaine; D009756:Nylidrin
Wirksamkeitsanalyse von Gerigoa- Depot in einer Doppelblindstudie